oa The correlation between azoospermia factor microdeletion in the Y chromosome and anti-sperm antibody generation in infertile Iraqi patients

References

1. Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics. 2013; 68::15–26.
   [Google Scholar]
2. Clements KM, Shipley CF, Coleman DA, Ehrhart EJ, Haschek WM, Clark SG. Azoospermia in an 8-month-old boar due to bilateral obstruction at the testis/epididymis interface. Can Vet J. 2010; 51:(10):1130.
   [Google Scholar]
3. Shaqalaih AJ. Genetic causes of male infertility in Gaza Strip-Palestine: A combined cytogenetic and Y chromosome microdeletions study. PhD Thesis, The Islamic Unviersity, Gaza, 2007.
   [Google Scholar]
4. Bichile DL, Kharkar AR, Menon P, Potnis-Lele M, Bankar M, Shroff GA. Y chromosome: Structure and biological functions. Indian J Basic Appl Med Res. 2014; 3::152–60.
   [Google Scholar]
5. Signore F, Gulìa C, Votino R, et al. The role of number of copies, structure, behavior and copy number variations (CNV) of the Y chromosome in male infertility. Genes (Basel). 2020; 11:(1):40.
   [Google Scholar]
6. Yu X-W, Wei Z-T, Jiang Y-T, Zhang S-L. Y chromosome azoospermia factor region microdeletions and transmission characteristics in azoospermic and severe oligozoospermic patients. Int J Clin Exp Med. 2015; 8:(9):14634.
   [Google Scholar]
7. Liu W-S. Mammalian sex chromosome structure, gene content, and function in male fertility. Annu Rev Anim Biosci. 2019; 7::103–24.
   [Google Scholar]
8. Khaleefah MH, Mossa HAL, Selman MO. Evaluation of anti sperm antibodies in relevance to progesterone levels in serum and seminal plasma in infertile men. Int J Pharm Phytopharm Res. 2018; 8:(5):48–52.
   [Google Scholar]
9. Marconi M, Weidner W. Site and risk factors of antisperm antibodies production in the male population. In:Krause W, Naz R (eds)Immune infertility. Springer, 2017, pp.133–47.
   [Google Scholar]
10. Vickram AS, Dhama K, Chakraborty S, et al. Role of antisperm antibodies in infertility, pregnancy, and potential for contraceptive and antifertility vaccine designs: Research progress and pioneering vision. Vaccines. 2019; 7:(3):116. doi: 10.3390/vaccines7030116.
    [Google Scholar]
11. Chowdhury SH. Male infertility-A global overview & Bangladesh perspective. J Curr Med Pract. 2019:32.
    [Google Scholar]
12. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 2010.
    [Google Scholar]
13. Al-Ouqaili MT, Al-Ani SK, Alaany R, Al-Qaisi MN. Detection of partial and/or complete Y chromosome microdele-tions of azoospermia factor a (AZFa) sub-region in infertile Iraqi patients with azoospermia and severe oligozoospermia. J Clin Lab Anal. 2022; 36:(3):1–9. doi: 10.1002/jcla.24272.
    [Google Scholar]
14. Krausz C, Hoefsloot L, Simoni M, Tüttelmann F. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: State-of-the-art 2013. Andrology. 2014; 2:(1):5–19. doi: 10.1111/j.2047-2927.2013.00173.x.
    [Google Scholar]
15. Khamees DA, Al-Ouqaili MTS. Cross-sectional study of chromosomal aberrations and immunologic factors in Iraqi couples with recurrent pregnancy loss. PeerJ. 2022; 10::e12801. doi: 10.7717/peerj.12801.
    [Google Scholar]
16. Atia T, Abbas M, Ahmed AF. Azoospermia factor microdeletion in infertile men with idiopathic severe oligozoo-spermia or non-obstructive azoospermia. African J Urol. 2015; 21:(4):246–53.
    [Google Scholar]
17. Khalaf SM, Shehab AF, AL-Asse AHAA. A molecular study of azoospermia & sever oligospermia in a sample of infertile males Al-Anbar Governorate. Eng Technol J. 2012; 30:(12):2116–24.
    [Google Scholar]
18. Hanoon RA, Raziq AH, Nerwey FF. AZF micro-deletion in azoospermia and severe oligospermia: Molecular & histopathological study in Duhok Province. Sci J Univ Zakho. 2017; 5:(3):239. doi: 10.25271/2017.5.3.354.
    [Google Scholar]
19. Khabour OF, Fararjeh AFS, Alfaouri AA. Genetic screening for AZF Y chromosome microdeletions in Jordanian azoospermic infertile men. Int J Mol Epidemiol Genet. 2014; 5:(1):47–50.
    [Google Scholar]
20. ElNahass YH, El Ahwany A, Zaghloul AS, et al. Y-Chromosome microdeletions and their association with male factor infertility in Egyptian patients. Life Sci J. 2017; 14:(6):66–72.
    [Google Scholar]
21. Al-Mahdawi MA, Al-Azzawi AA, Kadhem HKh. Investigation of azoospermia factor microdeletions in infertile men in Diyala Governorate. Iraqi J Embryos Infertil Res. 2018; 8:(2):43–9. doi: 10.28969/ijeir.v8.i2.r7.
    [Google Scholar]
22. Al-Qaisi MN, Al-Ouqaili MT, Al-Hadithi DT. Molecular analysis for azoospermia factor microdeletions in the Y chromosome for azoospermic and severe oligospermic infertile Iraqi patients. Syst Rev Pharm. 2020; 11:(8):562–70.
    [Google Scholar]
23. Fathi EI, Ibrahem S. The prevalence of serum and seminal fluid antisperm antibody in couples with unexplained subfertility in Kirkuk city. Indian J Public Heal Res Dev. 2019; 10:(8):2239–44.
    [Google Scholar]
24. Selman MO, Mossa HAL, Khaleefah MH. Evaluation of anti-sperm antibodies in relevance to testosterone levels in serum and seminal plasma in infertile men. Iraqi J Embryos Infertil Res. 2018; 8:(1):22–8.
    [Google Scholar]
25. Bozhedomov VA, Lipatova NA, Alexeev RA, Alexandrova LM, Nikolaeva MA, Sukhikh GT. The role of the anti-sperm antibodies in male infertility assessment after microsurgical varicocelectomy. Andrology. 2014; 2:(6):847–55.
    [Google Scholar]
26. Hoover P, Naz RK. Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma? Int J Androl. 2012; 35:(4):608–15.
    [Google Scholar]